Abstract

BackgroundSafety assessment of genetically modified organisms is currently often performed by comparative evaluation. However, natural variation of plant characteristics between commercial varieties is usually not considered explicitly in the statistical computations underlying the assessment.ResultsStatistical methods are described for the assessment of the difference between a genetically modified (GM) plant variety and a conventional non-GM counterpart, and for the assessment of the equivalence between the GM variety and a group of reference plant varieties which have a history of safe use. It is proposed to present the results of both difference and equivalence testing for all relevant plant characteristics simultaneously in one or a few graphs, as an aid for further interpretation in safety assessment. A procedure is suggested to derive equivalence limits from the observed results for the reference plant varieties using a specific implementation of the linear mixed model. Three different equivalence tests are defined to classify any result in one of four equivalence classes. The performance of the proposed methods is investigated by a simulation study, and the methods are illustrated on compositional data from a field study on maize grain.ConclusionsA clear distinction of practical relevance is shown between difference and equivalence testing. The proposed tests are shown to have appropriate performance characteristics by simulation, and the proposed simultaneous graphical representation of results was found to be helpful for the interpretation of results from a practical field trial data set.

Highlights

  • Safety assessment of genetically modified organisms is currently often performed by comparative evaluation

  • Equivalence testing for genetically modified organisms (GMOs) We developed a statistical methodology to assist in the comparative risk assessment of genetically modified (GM) crops

  • It is optimal to study the differences of the GMO with its non-GM counterpart

Read more

Summary

Introduction

Safety assessment of genetically modified organisms is currently often performed by comparative evaluation. In Europe, genetically modified organisms (GMOs) and derived products are allowed on the market after passing an approval system in which the safety for humans, animals and the environment is assessed. This safety assessment is performed by the GMO Panel of. In a later paper by Hothorn and Oberdoerfer [6] this fixed value was described as rigid and not reflecting the difference in variability between components, and component-specific safety ranges were proposed to be proportional to the variance of the concurrent control in the same field trials, which method ignores the amount of background variation found between commercial varieties. A simultaneous display of test results for multiple plant characteristics is advocated

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.